Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOPARIN for Atrial fibrillation: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 9 adverse event reports in the FDA FAERS database where CERTOPARIN was used for Atrial fibrillation.

Most Reported Side Effects for CERTOPARIN

Side Effect Reports % Deaths Hosp.
Pulmonary embolism 21 17.2% 0 9
Toxic epidermal necrolysis 19 15.6% 12 7
Haematoma 18 14.8% 0 8
Off label use 14 11.5% 0 1
Multiple organ dysfunction syndrome 12 9.8% 12 3
Stevens-johnson syndrome 12 9.8% 4 6
Haemorrhage 11 9.0% 0 0
Thrombosis 11 9.0% 0 1
Activated partial thromboplastin time prolonged 10 8.2% 0 0
Coagulation factor v level decreased 10 8.2% 0 0
Deep vein thrombosis 10 8.2% 0 9
Epistaxis 10 8.2% 1 0
Factor v inhibition 10 8.2% 0 0
Hepatic failure 10 8.2% 10 0
Myocardial infarction 10 8.2% 0 0

Other Indications for CERTOPARIN

Thrombosis prophylaxis (44) Product used for unknown indication (38) Embolism venous (10) Thrombophlebitis (6)

Other Drugs Used for Atrial fibrillation

RIVAROXABAN (52,584) DABIGATRAN ETEXILATE (20,492) APIXABAN (10,500) AMIODARONE (9,083) WARFARIN (8,680) EDOXABAN (3,855) ASPIRIN (2,993) DOFETILIDE (2,439) PRADAXA (2,325) METOPROLOL (1,542)

Related Pages

CERTOPARIN Full Profile All Atrial fibrillation Drugs CERTOPARIN Demographics CERTOPARIN Timeline